Moneycontrol PRO
Black Friday Sale
Black Friday Sale
HomeNewsBusinessMedlife acquires Bengaluru-based Myra Medicines

Medlife acquires Bengaluru-based Myra Medicines

Myra's acquisition will enable the company to strengthen its pharma business and accrue profits, Medlife said in a statement.

May 06, 2019 / 14:29 IST

Health-tech platform Medlife on May 6 said it has acquired Bengaluru-based medicine delivery startup, Myra Medicines.

Myra's acquisition will enable the company to strengthen its pharma business and accrue profits, Medlife said in a statement.

The company, however, did not provide financial details of the acquisition.

While Myra was earlier handling about 4,000 deliveries a day in Bengaluru alone, its services are now ready to be scaled across 22 cities this quarter, it added.

Medlife Founder and CEO Tushar Kumar said, "Our acquisition of Myra Medicines will be a game changer in the delivery of quality services for access to medicines".

Medlife is currently servicing over 20,000 deliveries every day across 29 states and having Myra on board will further strengthen its standing as a dependable and reliable partner for people's health, he added.

"Myra was established with the vision of ensuring timely access to medicines across the country. We have implemented the model successfully in Bengaluru; but now with Medlife's support, the services will be extended to several other cities," Myra Medicines Co-Founders Faizan Aziz and Anirudh Coontoor said.

PTI
first published: May 6, 2019 02:15 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

  • On Saturdays

    Find the best of Al News in one place, specially curated for you every weekend.

  • Daily-Weekdays

    Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347